These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 475369)

  • 1. In vitro of cefotaxime against cephalothin-resistant clinical isolates.
    Van Landuyt HW; Pyckavet M
    Antimicrob Agents Chemother; 1979 Jul; 16(1):109-11. PubMed ID: 475369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin.
    Jones RN; Fuchs PC; Barry AL; Gavan TL; Sommers HM; Gerlach EH
    Antimicrob Agents Chemother; 1980 Apr; 17(4):743-9. PubMed ID: 6446879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae.
    Verbist L; Verhaegen J
    Antimicrob Agents Chemother; 1980 May; 17(5):807-12. PubMed ID: 6994640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT; Prignano G; Iegri F; Lorenzi A
    Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL; Schoenknect FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates.
    Jones RN; Fuchs PC
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1066-9. PubMed ID: 938021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1976 Jun; 9(6):994-9. PubMed ID: 938029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolates.
    Jones RN; Fuchs PC; Gavan TL; Gerlach EH; Barry A; Thornsberry C
    J Antibiot (Tokyo); 1977 Jul; 30(7):576-82. PubMed ID: 893226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of antibacterial activity of cephapirin with cephalothin and cephaloridine to various pathogenic bacteria recently isolated from clinical materials (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1974 Apr; 27(2):157-63. PubMed ID: 4211361
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
    Jorgensen JH; Crawford SA; Alexander GA
    Antimicrob Agents Chemother; 1980 Jun; 17(6):937-42. PubMed ID: 6250470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of cefoperazone, cefotaxime, cefuroxime, and cephalothin against 128 clinical isolates.
    Garcia-Rodriguez JA
    Clin Ther; 1980; 3(Spec Issue):117-22. PubMed ID: 6248220
    [No Abstract]   [Full Text] [Related]  

  • 12. [In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
    Berche P; Gaillard JL
    Ann Biol Clin (Paris); 1986; 44(6):624-7. PubMed ID: 3826779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity of five cephalosporins.
    Mutton KJ; Harkness JL
    Pathology; 1981 Jan; 13(1):73-7. PubMed ID: 6784093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
    Meyer RD
    J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinico-microbiologic bases for the use of new cephalosporins].
    De Bac C; Mascellino MT; Nuti M
    Minerva Med; 1982 Apr; 73(15):899-903. PubMed ID: 6979006
    [No Abstract]   [Full Text] [Related]  

  • 16. Cefotaxime, cephalothin, and cephapirin: antimicrobial activity and synergy studies of cephalosporins with significant in vivo desacetyl metabolite concentrations.
    Jones RN; Packer RR
    Diagn Microbiol Infect Dis; 1984 Jan; 2(1):65-8. PubMed ID: 6100364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.
    Fuchs PC; Barry AL; Thornsberry C; Jones RN; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1980 Jul; 18(1):88-93. PubMed ID: 6251750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J
    Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolates.
    Jones RN; Fuchs PC; Gavan TL; Gerlach EH; Barry AL; Thornsberry C
    Antimicrob Agents Chemother; 1977 Jul; 12(1):47-50. PubMed ID: 883818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
    Shah PP; Briedis DJ; Robson HG; Conterato JP
    Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.